Obermatt

Crescent Biopharma

NAQ:CBIO · KYG2545C1042
BiotechnologyX-Small

360° View

19
Price/Sales15
Price/Earnings70
Price/Book25
Dividend Yield
Revenue Growth1
Profit Growth42
Capital Growth85
TSR 52w24
Leverage81
Liquidity17
Refinancing55
Combined32
Analyst Opinions31
Pro Holdings51
Opinion Changes29
Market Pulse9

Profile

CountryUSA
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
ISINKYG2545C1042
Last UpdateApr 2, 2026
Index & Theme
OncologyBiotechnologyHealth CareMedical Device

Description

Analysis

Crescent Biopharma's 360° View rank of 19 places it among the weakest overall — better than 19% of its true peers.

It's growing solidly (61) and on the expensive side (37). On safety it is carrying more balance-sheet risk (47), and the market shows skeptical sentiment (11). Taken together, its Combined rank of 32 reads as below its peer average.

360° rank · history

1007550250
19
2026

All-time high

43

Mar 2026

All-time low

19

Jun 2026

Average rank

31

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
15
Price/Earnings
70
Price/Book
25
Dividend Yield
Value (overall)
37

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Crescent Biopharma with its peers
ArriVent BioPharma
NMQ:AVBP
89
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Sutro Biopharma
NMQ:STRO
16
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Celcuity
NAQ:CELC
96
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Sellas Life Sciences
NAQ:SLS
62
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Zymeworks
NSQ:ZYME
43
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Vir Biotechnology
NSQ:VIR
56
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →